262 related articles for article (PubMed ID: 23266519)
1. Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation.
Takahashi N; Wada H; Usui M; Kobayashi T; Habe-Ito N; Matsumoto T; Uemoto S; Nobori T; Isaji S
Thromb Res; 2013 Mar; 131(3):225-9. PubMed ID: 23266519
[TBL] [Abstract][Full Text] [Related]
2. Decreased ADAMTS13 levels in patients after living donor liver transplantation.
Kobayashi T; Wada H; Usui M; Sakurai H; Matsumoto T; Nobori T; Katayama N; Uemoto S; Ishizashi H; Matsumoto M; Fujimura Y; Isaji S
Thromb Res; 2009 Nov; 124(5):541-5. PubMed ID: 19423151
[TBL] [Abstract][Full Text] [Related]
3. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.
Habe K; Wada H; Ito-Habe N; Hatada T; Matsumoto T; Ohishi K; Maruyama K; Imai H; Mizutani H; Nobori T
Thromb Res; 2012 May; 129(5):598-602. PubMed ID: 22070827
[TBL] [Abstract][Full Text] [Related]
4. Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome.
Ito-Habe N; Wada H; Matsumoto T; Ohishi K; Toyoda H; Ishikawa E; Nomura S; Komada Y; Ito M; Nobori T; Katayama N
Int J Hematol; 2011 Jan; 93(1):47-52. PubMed ID: 21153061
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy.
Yamashita Y; Naitoh K; Wada H; Ikejiri M; Mastumoto T; Ohishi K; Hosaka Y; Nishikawa M; Katayama N
Thromb Res; 2014 Mar; 133(3):440-4. PubMed ID: 24325877
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.
Hori T; Kaido T; Oike F; Ogura Y; Ogawa K; Yonekawa Y; Hata K; Kawaguchi Y; Ueda M; Mori A; Segawa H; Yurugi K; Takada Y; Egawa H; Yoshizawa A; Kato T; Saito K; Wang L; Torii M; Chen F; Baine AM; Gardner LB; Uemoto S
World J Gastroenterol; 2011 Apr; 17(14):1848-57. PubMed ID: 21528059
[TBL] [Abstract][Full Text] [Related]
7. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome.
Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Tsuda K; Kondo M; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
Clin Appl Thromb Hemost; 2017 Sep; 23(6):622-630. PubMed ID: 26759371
[TBL] [Abstract][Full Text] [Related]
8. Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases.
Ko S; Okano E; Kanehiro H; Matsumoto M; Ishizashi H; Uemura M; Fujimura Y; Tanaka K; Nakajima Y
Liver Transpl; 2006 May; 12(5):859-69. PubMed ID: 16528712
[TBL] [Abstract][Full Text] [Related]
9. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.
Peyvandi F; Siboni SM; Lambertenghi Deliliers D; Lavoretano S; De Fazio N; Moroni B; Lambertenghi Deliliers G; Mannuccio Mannucci P
Br J Haematol; 2006 Jul; 134(2):187-95. PubMed ID: 16846477
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli.
Murphy SJX; Lim ST; Hickey F; Kinsella JA; Smith DR; Tierney S; Egan B; Feeley TM; Murphy SM; Collins DR; Coughlan T; O'Neill D; Harbison JA; Madhavan P; O'Neill SM; Colgan MP; O'Donnell JS; O'Sullivan JM; Hamilton G; McCabe DJH
Thromb Haemost; 2021 Jan; 121(1):86-97. PubMed ID: 32932544
[TBL] [Abstract][Full Text] [Related]
11. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
[TBL] [Abstract][Full Text] [Related]
12. Linear relationship between ADAMTS13 activity and platelet dynamics even before severe thrombocytopenia.
Song J; Lee KA; Park TS; Park R; Choi JR
Ann Clin Lab Sci; 2008; 38(4):368-75. PubMed ID: 18988930
[TBL] [Abstract][Full Text] [Related]
13. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies.
Farkas P; Csuka D; Mikes B; Sinkovits G; Réti M; Németh E; Rácz K; Madách K; Gergely M; Demeter J; Prohászka Z
Immunobiology; 2017 Feb; 222(2):119-127. PubMed ID: 27771173
[TBL] [Abstract][Full Text] [Related]
14. Von Willebrand Factor Deposition and ADAMTS-13 Consumption in Allograft Tissue of Thrombotic Microangiopathy-like Disorder After Living Donor Liver Transplantation: A Case Report.
Nakanuma S; Miyashita T; Hayashi H; Ohbatake Y; Takamura H; Okazaki M; Yamaguchi T; Sakai S; Makino I; Oyama K; Tajima H; Ninomiya I; Fushida S; Ohta T
Transplant Proc; 2017 Sep; 49(7):1596-1603. PubMed ID: 28651806
[TBL] [Abstract][Full Text] [Related]
15. ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA).
Kobayashi T; Wada H; Nishioka N; Yamamoto M; Matsumoto T; Tamaru T; Nomura S; Masuya M; Mori Y; Nakatani K; Nishikawa M; Katayama N; Nobori T
Thromb Res; 2008; 121(6):849-54. PubMed ID: 17900666
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor--cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report.
Nakazawa Y; Hashikura Y; Urata K; Ikegami T; Terada M; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y; Miyagawa S
Liver Transpl; 2003 Dec; 9(12):1328-33. PubMed ID: 14625834
[TBL] [Abstract][Full Text] [Related]
17. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
18. ADAMTS13 protease or lack of von Willebrand factor protects irradiation and melanoma-induced thrombotic microangiopathy in zebrafish.
Zheng L; Cao L; Zheng XL
J Thromb Haemost; 2022 Oct; 20(10):2270-2283. PubMed ID: 35894519
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
[TBL] [Abstract][Full Text] [Related]
20. Elevated Soluble Platelet Glycoprotein VI Levels in Patients After Living Donor Liver Transplantation.
Takahashi N; Usui M; Naitoh K; Wada H; Mastsui T; Kobayashi T; Matsumoto T; Uemoto S; Isaji S
Clin Appl Thromb Hemost; 2017 Apr; 23(3):274-281. PubMed ID: 26346441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
